The patient engagement engine for pharma portfolios

Behavior-driven digital engagement that helps pharmaceutical brands activate patients, improve outcomes, and scale support across therapies and markets.

IQVIA validated

/

13M+ patients supported

/

25+ pharma partners

/

150+ countries

/

up to 50x ROI

/

NIH published research

IQVIA validated

/

13M+ patients supported

/

25+ pharma partners

/

150+ countries

/

up to 50x ROI

/

NIH published research

/

IQVIA validated

/

13M+ patients supported

/

25+ pharma partners

/

150+ countries

/

up to 50x ROI

/

NIH published research

/

IQVIA validated

/

13M+ patients supported

/

25+ pharma partners

/

150+ countries

/

up to 50x ROI

/

NIH published research

/

Helping pharma connect with patients beyond the prescription

Medisafe helps brands extend support directly into patients' daily lives, activating patients earlier, keeping them engaged in therapy longer, and generating measurable outcomes across the treatment journey.

Therapeutic Areas

Built for complex therapies

Medisafe works with pharmaceutical companies across complex and specialty therapies where sustained patient engagement is critical to outcomes.

Cardiovascular

Immunology

Mental Health

Metabolic / GLP-1

Neurology

Oncology

Proven Results

Turning your program goals into achievable outcomes

Increase in medication adherence
15%
Increase in time on therapy
17%
Adherence lift in specialty therapies
43%
Reduction in claims events
34%
60-day retention
93%
Program ROI up to
Up to
50x

Validated through research with

IQVIA

/

Vanderbilt University / NIH

/

Komodo Health

Resource Library

Insights for pharma brand teams

Research, case studies, and perspectives on digital companions, adherence science, and patient engagement.

Article
Jul 14, 2026
The Hidden Cost of Caregiver Notification Fatigue

Notification fatigue is reshaping caregiver engagement. Behavioral intelligence helps identify when caregiver support can have the greatest impact.

Continue Reading

Article
Jul 9, 2026
The Adherence Patterns Shaping Oncology Outcomes

See how behavioral intelligence helps pharmaceutical organizations improve oncology adherence, patient engagement, and long-term treatment persistence.

Continue Reading

Article
Jul 7, 2026
The Role of Memory, Routine, and Behavior in Neurology Adherence

Explore how memory, routine, and patient behavior influence neurology adherence and discover new strategies to improve engagement and long-term persistence.

Continue Reading

Article
Jun 26, 2026
Improving Adherence Across Complex Biologic Therapies

Learn how dynamic, personalized support, through Medisafe's Digital Drug Companion, is reshaping adherence across complex biologic therapies and closing gaps in traditional patient programs.

Continue Reading

Research
Jun 12, 2026
IQVIA Research: The Link Between Digital Engagement and Therapy Persistence

Discover how an IQVIA study found Digital Companion users were significantly more likely to remain on therapy, providing new evidence for the impact of digital patient support.

Continue Reading

Article
Jun 12, 2026
Personalized Digital Support for Chronic Disease Management

New insights reveal how personalized digital support can drive behavior change, improve medication adherence, and strengthen patient outcomes at scale.

Continue Reading

Bring patient engagement closer to the therapy

See how Medisafe helps pharmaceutical teams activate patients, improve adherence, and measure outcomes across their portfolio.